Breast Cancer
Research on breast cancer discussed by scientists at Brown University
Published in Women's Health Weekly, November 12th, 2009
In this recent study, researchers in the United States conducted a study "To evaluate the efficacy and safety of neoadjuvant carboplatin and weekly paclitaxel +/- weekly trastuzumab in resectable and locally advanced breast cancer. Women with stages IIA to IIIB disease received carboplatin dosed by six times the area under the curve every 4 weeks and paclitaxel 80 mg/m(2) weekly for 16 weeks, and weekly trastuzumab was added for human epidermal growth factor receptor 2 (HER2)-positive status."
"The primary end point was the pathologic complete response (pCR) rate, defined as the absence of invasive disease in the breast and axillary nodes. Postoperative therapies were...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly
More Articles from Women's Health Weekly
- Alcoholism
Scientists identify a cellular pathway by which alcohol may promote cancer progression - American Cancer Society
Study finds delay in follow-up among African-American women receiving abnormal breast finding - Cell Transplantation Center of Excellence for Aging and Brain Repair
Placental precursor stem cells require testosterone-free environment to survive - Elsevier Health Sciences
Study shows hormone replacement therapy decreases mortality in younger postmenopausal woman - JAMA and Archives Journals
Alternative to pap test does not appear to be better for detecting cervical cancer - Journal of the National Cancer Institute
Breast cancer incidence in Spain drops in early 2000s after decades of increasing rates - More from this issue of Women's Health Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
